Relationship Between Laboratory-Measured HbA1c and Continuous Glucose Monitoring–Derived Glucose Management Indicator in Adults With Cystic Fibrosis–Related Diabetes
Cystic fibrosis (CF) diabetes is characterized by progressive destruction of -cells, dysfunctional and inadequate insulin secretion, and fluctuating insulin resistance.
Authors
- Parag Yajnik
- D. Lau
- Nithya Kadiyala (ORCID: https://orcid.org/0000-0003-4285-4656)
- I. Felton
- A. M. Nugent
- Andrew Clayton
- Gordon MacGregor (ORCID: https://orcid.org/0000-0002-8455-3424)
- Yee Seun Cheah
- Amanda Brennan
- Amanda I. Adler
- Richard I G Holt
- Laura Barlow
- Alistair Lumb
- Roman Hovorka
- Charlotte K. Boughton
Institutions
- Belfast Health and Social Care Trust (GB)
- St Bartholomew's Hospital (GB)
- Barts Health NHS Trust (GB)
- Royal Papworth Hospital (GB)
- University Hospitals of North Midlands NHS Trust (GB)
- University Hospitals Bristol NHS Foundation Trust (GB)
- Churchill Hospital (GB)
- University Hospitals of Leicester NHS Trust (GB)
- Cambridge University Hospitals NHS Foundation Trust (GB)
- Manchester University NHS Foundation Trust (GB)
- Royal Brompton Hospital (GB)
- King's College Hospital NHS Foundation Trust (GB)
- Wellcome/MRC Institute of Metabolic Science (GB)
- Oxford Centre for Diabetes, Endocrinology and Metabolism (GB)
- University Hospital Llandough (GB)
- Queen Elizabeth University Hospital (GB)
- University of Southampton (GB)
Publication Details
- Journal
- Diabetes Care
- Published
- 2026-01-13
- DOI
- https://doi.org/10.2337/dc25-2936
- Primary Topic
- Cystic Fibrosis Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Eli Lilly and Company
- Sanofi
- Dexcom
- National Institute for Health and Care Research
- University of Oxford
- European Foundation for the Study of Diabetes
- Novo Nordisk
- Abbott Diabetes Care
- NIHR Oxford Biomedical Research Centre
- NIHR Cambridge Biomedical Research Centre